Clinical and laboratory investigations on man: systemic administration of potent interferon to man.
D000328:Adult; D000368:Aged; D000818:Animals; D000941:Antigens / Q000032:analysis; D000956:Antigens, Viral / Q000032:analysis; D001789:Blood Group Antigens; D001799:Blood Sedimentation; D002478:Cells, Cultured; D002645:Chickens / Q000276:immunology; D003168:Complement Fixation Tests; D005069:Evaluation Studies as Topic; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006562:Herpes Zoster / Q000628:therapy; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007962:Leukocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009174:Mycoplasma / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D018108:Respirovirus / Q000276:immunology; D012412:Rubella virus / Q000276:immunology; D014777:Virus Diseases / Q000150:complications
D000941:Antigens; D000956:Antigens, Viral; D001789:Blood Group Antigens; D007372:Interferons